Target intelligence / Profile preview

5',3'-Nucleotidase, cytosolic pseudogene 2 (NT5CP2)

Target
NT5CP2
Molecular classification
Other (pseudogene)
01

Overview

5',3'-Nucleotidase, cytosolic pseudogene 2 (NT5CP2) is classified as a pseudogene, which means it is a non-functional gene sequence that is related to protein-coding 5'-nucleotidase family genes, but does not produce a functional protein product or have a known biological role[1]. Unlike NT5C3 or NT5C2, which encode active enzymes involved in nucleotide metabolism and are studied in disease, NT5CP2 is annotated as a pseudogene without evidence of therapeutic relevance or druggability[1][2]. Thus, NT5CP2 is not a recognized receptor, enzyme, transporter, or other common therapeutic target. There is nothing to support NT5CP2 as a functional, druggable, or disease-associated molecule; any association with therapy, mechanism, or biomarker status is not currently recognized in major scientific resources[1][2]. The main error is that NT5CP2 itself is a pseudogene and not a protein-coding target. If you intended to ask about Cytosolic 5'-nucleotidase 3 (NT5C3), which is a functional enzyme and a drug metabolism target, please clarify, as that is a distinct, biologically active protein[2].

Other names
5',3'-nucleotidase cytosolic pseudogene 2NT5CP2

Beyond the preview

Go deeper on 5',3'-Nucleotidase, cytosolic pseudogene 2 (NT5CP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5',3'-Nucleotidase, cytosolic pseudogene 2 (NT5CP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call